홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Hydrogen Bromide → 6,7-Dihydroxyquinazolin-4(3h)-one

HRID 1846127
인쇄

반응식

HRID 1846127 반응식
COCCOC1C=C2C(NC3C=CC=C(C#C)C=3)=NC=NC2=CC=1OCCOC.Cl.C[O:32][C:33]1[CH:34]=[C:35]2[C:40](=[CH:41][C:42]=1[O:43]C)[N:39]=[CH:38][NH:37][C:36]2=[O:45].Br.N1C=CC=CC=1.Cl>>[OH:32][C:33]1[CH:34]=[C:35]2[C:40](=[CH:41][C:42]=1[OH:43])[N:39]=[CH:38][NH:37][C:36]2=[O:45]
참가 물질실험 절차출처 및 근거반응 노트

참가 물질

5

반응물 4

HCID 260Hydrogen BromideHCID 176871Erlotinib HydrochlorideHCID 10176127Pyridinium chlorideHCID 1354950166,7-Dimethoxy-3H-quinazolin-4-one

생성물 1

HCID 1357422586,7-Dihydroxyquinazolin-4(3h)-one

실험 절차

A method for the preparation of erlotinib hydrochloride was disclosed in US 2009/0306377. The method, illustrated in Scheme 2, involves treating 6,7-dimethoxy-4(3H)-quinazolone (5) with hydrobromic acid or pyridine-hydrochloric acid to afford 6,7-dihydroxy-4(3H)-quinazolone (6), which was diacetylated with acetic anhydride to afford diester (7), which was treated with oxalyl chloride/DMF to afford 4-chloro-6,7-diacetoxyquinazoline (8). Compound (8) was condensed with 3-ethynylaniline to afford N-(3-ethynylphenyl)-6,7-dihydroxy-4-quinazolinamine hydrochloride (9), which was converted into the diol N-(3-ethynylphenyl)-6,7-dihydroxy-4-quinazolinamine (10) by treatment with aqueous ammonia/methanol. The diol (10) was treated with 2-iodo-ethylmethyl ether to yield compound (4) which on treatment with HCl afforded erlotinib hydrochloride (1). However, this preparation of erlotinib hydrochloride is a long synthetic route and gives low yields and requires very toxic reagents like pyridine, HBr and controlled reagents like acetic anhydride. Hence, it is not suitable for large scale production.

출처 및 근거

ORD 기록
ord-5fd7229cec7049f6bfe2864588b6348e
출처 데이터셋
uspto-grants-2015_02
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08952022B2

반응 노트

이 페이지에서참가 물질실험 절차출처 및 근거반응 노트